BDO USA Expands Product Development Advisory Services in Life Sciences Through Addition of BioProcess Technology Consultants

BDO USA Expands Product Development Advisory Services in Life Sciences Through Addition of BioProcess Technology Consultants

5 years ago
Anonymous $Dftgs0JzgE

https://www.businesswire.com/news/home/20190401005124/en/

CHICAGO--(BUSINESS WIRE)--Apr 1, 2019--BDO USA, LLP, one of the nation’s leading professional services organizations, today announced the acquisition of BioProcess Technology Consultants, Inc. (BPTC), a provider of chemistry, manufacturing and controls (CMC) consulting services to the global biopharmaceutical industry. The acquisition of BPTC bolsters BDO’s capabilities in the life sciences industry within the biopharmaceutical product development space and is effective as of April 1, 2019.

“We are pleased to welcome BPTC’s knowledge and resources to enhance our focus in the life sciences industry and deepen our biopharmaceutical product development offerings,” said Eric Jia-Sobota, national leader of BDO’s Industry Specialty Services and Life Sciences practices. “Joining forces with BPTC strengthens our ability to assist life sciences companies in managing risk, maximizing profitability and fostering continued innovation to unlock new value and deliver improved outcomes.”

BDO USA Expands Product Development Advisory Services in Life Sciences Through Addition of BioProcess Technology Consultants

Apr 1, 2019, 1:30pm UTC
https://www.businesswire.com/news/home/20190401005124/en/ > CHICAGO--(BUSINESS WIRE)--Apr 1, 2019--BDO USA, LLP, one of the nation’s leading professional services organizations, today announced the acquisition of BioProcess Technology Consultants, Inc. (BPTC), a provider of chemistry, manufacturing and controls (CMC) consulting services to the global biopharmaceutical industry. The acquisition of BPTC bolsters BDO’s capabilities in the life sciences industry within the biopharmaceutical product development space and is effective as of April 1, 2019. > “We are pleased to welcome BPTC’s knowledge and resources to enhance our focus in the life sciences industry and deepen our biopharmaceutical product development offerings,” said Eric Jia-Sobota, national leader of BDO’s Industry Specialty Services and Life Sciences practices. “Joining forces with BPTC strengthens our ability to assist life sciences companies in managing risk, maximizing profitability and fostering continued innovation to unlock new value and deliver improved outcomes.”